Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Leases (2022 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Leases for 4 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Leases fell 25.39% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 25.39% year-over-year, with the annual reading at $4.2 million for FY2025, 25.39% down from the prior year.
  • Leases for Q4 2025 was $4.2 million at Fulcrum Therapeutics, down from $4.6 million in the prior quarter.
  • The five-year high for Leases was $10.4 million in Q1 2022, with the low at $4.2 million in Q4 2025.
  • Average Leases over 4 years is $7.2 million, with a median of $6.9 million recorded in 2023.
  • The sharpest move saw Leases fell 17.17% in 2023, then decreased 25.39% in 2025.
  • Over 4 years, Leases stood at $9.1 million in 2022, then dropped by 20.82% to $7.2 million in 2023, then fell by 20.79% to $5.7 million in 2024, then decreased by 25.39% to $4.2 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $4.2 million, $4.6 million, and $5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.